2,6-Dimethoxyquinone

CAS No. 530-55-2

2,6-Dimethoxyquinone( —— )

Catalog No. M18744 CAS No. 530-55-2

2, 6-dimethoxy-1, 4-benzoquinone is a member of the class of compounds known as P-benzoquinones.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 28 In Stock
50MG 37 In Stock
100MG 45 In Stock
200MG 69 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2,6-Dimethoxyquinone
  • Note
    Research use only, not for human use.
  • Brief Description
    2, 6-dimethoxy-1, 4-benzoquinone is a member of the class of compounds known as P-benzoquinones.
  • Description
    2, 6-dimethoxy-1, 4-benzoquinone is a member of the class of compounds known as P-benzoquinones. 2, 6-dimethoxy-1, 4-benzoquinone is slightly soluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). It is a benzoquinone, a chemical compound found in Rauvolfia vomitoria, in Tibouchina pulchra, and in common wheat.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    530-55-2
  • Formula Weight
    168.15
  • Molecular Formula
    C8H8O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5.56 mg/mL (33.07 mM)
  • SMILES
    O=C1C(=CC(=O)C=C1OC)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Naloxegol oxalate

    Naloxegol (NKTR-118 and AZ-13337019), is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation.

  • Ambroxol

    Ambroxol is indicated as "secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.

  • Bergapten

    5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo.